Inhibition of tumor cell proliferation by type IV collagen requires increased levels of cAMP

Connective Tissue Research

Volumn 40, Issue 3, 1999, Pages 221-232

  Shahan, Tracy A ^a   Ohno, Nobuko ^a   Pasco, Sylvie ^b   Borel, Jacques P ^b   Monboisse, Jean Claude ^b   Kefalides, Nicholas A ^a  

^a The Science Center Philadelphia   (United States)

^b UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

Author keywords

cAMP; Cell proliferation; Tumor cell; Type IV collagen; 3(IV) chain

Indexed keywords

EID: 0032811677     PISSN: 03008207     EISSN: None     Source Type: Journal    
DOI: 10.3109/03008209909005285     Document Type: Article

References (25)

1. Monboisse, J.C., Garnotel. R., Bellon, G.. Ohno, N., Perreau, C., Borel, J.P. and Kefalides, N.A. (1994). The α3 chain of type IV collagen prevents activation of human polymorphonuclear leukocytes. J. Biol. Chem., 269, 25475-25482.
2. Han, J., Monboisse, J.C., Pasco, S., Borel, J.P. and Kefalides, N.A. (1997). A cell binding domain from the α3 chain of type IV collagen inhibits proliferation of melanoma cells. J. Biol. Chem., 272, 20395-23401.
3. Chen, T.C, Hinton, D.R., Zidovetzki, R. and Hofman, F.M. (1998). Up-regulation of the cAMP/PKA pathway inhibits proliferation, induces differentiation, and leads to apoptosis in malignant gliomas. Lab. Invest., 78, 165-174.
4. D'Angelo, G., Lee, H. and Weiner, R.I. (1997). cAMP-dependent protein kinase inhibits the mitogenic action of vascular endothelial growth factor and fibroblast growth factor in capillary endothelial cells by blocking Raf activation. J. Cell. Biochem., 67, 353-366.
5. Berlin, B., Jockers, R., Strosberg, A.D. and Marullo, S. (1997). Activation of a beta 2-adrenergic receptor/Gs alpha fusion protein elicits a desensitization-resistant cAMP signal capable of inhibiting proliferation of two cancer cell lines. Receptors and Channels, 5, 41-51.
6. Indolfi, C, Avvedimento, E.V., Di Lorenzo, E., Esposito, G., Rapacciuolo, A., Giuliano, P., Grieco, D., Cavuto, L., Stingone, A.M., Ciullo, I., Condorelli, G. and Chiariello, M. (1997). Activation of cAMP-PKA signaling in vivo inhibits smooth muscle cell proliferation induced by vascular injury. Nature Medicine, 3, 775-779.
7. Starzec, A.B., Spanakis, E., Nehme, A., Salle, V., Veber, N., Mainguene, C., Pianchon, P., Valette, A., Prevost, G. and Israel, L. (1994). Proliferative responses of epithelial cells to 8-bromo-cyclic AMP and to a phorbol ester change during breast pathogenesis. J. Cell. Phys., 161, 31-38.
8. Wisdom, Jr., B.J., Gunwar, S., Hudson, M.D., Noelken, M.E. and Hudson, B.C. (1992). Type IV collagen of Engelbreth-Holm Swarm tumor matrix: Identification of constituent chains. Connective Tissue Research, 27, 225-234.
9. Herlyn, M., Kath, R., Williams, N., Valyi-Nagy, I. and Rodeck, U. (1989). Growth-regulatory factors for normal, premalignant, and malignant human cells in vitro. Adv. Cancer Res., 54, 213-234.
10. Herlyn, M. (1990). Human melanoma: development and progression. Cancer Metastasis Rev., 9, 101-112.
11. Brinker, J.M., Pegg, M.T., Howard, P.S. and Kefalides, N.A. (1985). Immunochemical characterization of type IV procollagen from anterior lens capsule. Collagen Related Research., 5, 233-244.
12. Kleinman, H.K., McGarvery. M.L., Liotta, L.A., Robey, P.G., Tryggvason, K. and Martin, R.G. (1982). Isolation and characterization of type IV procollagen, laminin, and heparan sulfate proteoglycan from the EHS sarcoma. Biochemistry, 21, 6188-6193.
13. Kefalides, N.A., Ohno, N., Wilson, C.B., Fillit, H., Zabriski, J. and Rosenbloom, J. (1994). Identification of antigenic epitopes in type IV collagen by use of synthetic peptides. Kidney Int., 43, 94-100.
14. Barany, G. and Merrifield, R.B. (1980). The Peptides, E. Gross and J. Meinhofer (Eds.), Vol. II, pp. 1-284, Academic Press, New York, NY.
15. Feng, L., Xia, Y. and Wilson, C.B. (1994). Alternative splicing of the NCI domain of the human alpha 3(IV) collagen gene. Differential expression of mRNA transcripts that predict three protein variants with distinct carboxyl regions. J. Biol. Chem., 269, 2342-2348.
16. 3H]thymidine incorporation assay. J. Immuno. Meth., 170, 211-224.
17. Chijiwa, T., Mishima, A., Hagiwara, M., Sano, M., Hayashi, K., Inoue, T., Naito, K., Toshioka, T. and Hidaka, H. (1990). Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclicAMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells. J. Biol. Chem., 265, 5267-5273.
18. Fujihara, M., Muroi, M., Muroi, Y., Ito, N. and Suzuki, T. (1993). Mechanism of lipopolysaccharide-triggered junB activation in a mouse macrophage-like cell line (J774). J. Biol. Chem., 268, 14898-14905.
19. Inagaki, M., Kawamoto, S.. Itoh, H., Saitoh, M., Hagiwara, J., Takahashi, J. and Hidaka, H. (1986). Naphthalenesulfonamides as calmodulin antagonists and protein kinase inhibitors. Mol. Pharmacol., 29, 577-578.
20. Schaap, P.J., van Ments-Cohen, M., Soede, R.D., Brandt, R.A., Firtel, R.A., Dostmann, W., Genieser, H.G., Jastorif, B. and van Haastert, PJ. (1993). Cell-permeable non-hydrolyzable cAMP derivatives as tools for analysis of signaling pathways controlling gene regulation in Dictyostelium. J. Biol. Chem., 268, 6323-6329.
21. Mayer, S.E., Stull, J.T., Wastilla, W.B., Hardman, J.C. and O'Malley, B.W. (1974). Isolation of cAMP from liver. Methods in Enzymotogy, Academic Press, New York, NY.
22. Dowdy, S. and Wearden, S. (1983). Statistics for Research, R.A. Bradley, J.S. Hunter, D.G. Kendall, R.G. Miller and G.S. Watson (Eds.), Wiley, New York.
23. Burridge, K., Path, K., Kelly, T., Nuckolls, G. and Turner, C. (1988). Annu. Rev. Cell. Biol., 4, 487-525.
24. D'Angelo, G., Lee, H. and Weiner, R.I. (1997). cAMP-dependent protein kinase inhibits the mitogenic action of vascular endothelial growth factor and fibroblast growth factor in capillary endothelial cells by blocking Raf activation. J. Cell. Biochem., 67, 353-366.
25. O'Reilly, M.S., Boehm, Y., Fukai, N., Vasios, G., Lane, E., Flynn, E.. Birkhead, J.R., Olsen, B.R. and Folkman, J. (1997). Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell, 88, 277-285.